Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
Filter by Categories
Backgrounder
Blog
Council Resource
Event
Handbook
Infographic
Issue Brief
Member Spotlight
News
Partner Resource
Policy Recommendation
Press Release
Report
Statement
Video

Resources

June 25, 2019
Patent “thicketing” occurs when a brand-name pharmaceutical company accumulates dozens of patents near the end of the product lifecycle under the guise of “innovative” processes or development that warrant additional protections
benefit of biosimilars
June 24, 2019
Dr. Sameer Awsare sat down with the Biosimilars Council to talk about biosimilars, their benefits and the hurdles to adoption in the United States. Watch the interview to hear his informed perspective.
June 11, 2019
This summer, as part of our commitment to broad stakeholder education about the promise of biosimilars, the Biosimilars Council will launch the first in a series of “member spotlights” – in-depth content featuring experts from our member companies sharing their unique experience and perspective on timely issues impacting the emerging biosimilars marketplace.
June 11, 2019
We’re thrilled to kick our Spotlight Series off this month with Dr. Hillel Cohen, Executive Director of Scientific Affairs for Sandoz.
brand name over biosimilar coverage
May 30, 2019
UnitedHealthcare’s (UHC) recent announcement that it will begin preferring brand name biologics over lower priced FDA-approved biosimilars is a step backwards in patient care.
May 17, 2019
We look forward to continuing to work with CMS to align coverage and payment policies to increase patient access to more affordable biosimilar and generic medicines.

Want to keep up to date with the biosimilars industry?

Sign up for Biosimilars Council Newsletter to hear about the field, learn about events, and find out how you can make an impact.

SIGN UP FOR OUR NEWSLETTER